Organization
AIDS Malignancy Consortium
17 clinical trials
Clinical trial
ANCHOR Study: Anal Cancer/HSIL Outcomes Research StudyStatus: Active (not recruiting), Estimated PCD: 2021-08-06
Clinical trial
A Phase 2 Trial of Ixazomib for Kaposi SarcomaStatus: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
A Randomized, Phase III Study of Intra-anal Imiquimod 2.5% vs. Topical 5-fluorouracil 5% vs. Observation for the Treatment of High-grade Anal Squamous Intraepithelial Lesions in HIV-infected Men and WomenStatus: Active (not recruiting), Estimated PCD: 2023-12-05
Clinical trial
Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin LymphomaStatus: Not yet recruiting, Estimated PCD: 2026-01-31
Clinical trial
A Phase II Multicenter Study of Pomalidomide Monotherapy in HIV-Positive Individuals With Kaposi Sarcoma (KS) in Sub-Saharan Africa (SSA)Status: Active (not recruiting), Estimated PCD: 2024-11-29
Clinical trial
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected MenStatus: Completed, Estimated PCD: 2010-05-01
Clinical trial
A Phase 2 Evaluation of VGX-3100, a Synthetic DNA Immunotherapy Targeting Human Papillomavirus 16 and 18 E6 and E7 Proteins, for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) in HIV-Positive IndividualsStatus: Active (not recruiting), Estimated PCD: 2029-09-20
Clinical trial
A Phase III, Randomized, Open-Label, Non-Inferiority Study of Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma in Resource-Limited SettingsStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Clinical trial
A Single-Arm, Open-Label Pilot Study of the Safety and Immunogenicity of the Merck Quadrivalent Human Papillomavirus Vaccine Among HIV-Positive Women in IndiaStatus: Completed, Estimated PCD: 2012-11-01
Clinical trial
A Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Children and AdultsStatus: Not yet recruiting, Estimated PCD: 2028-08-01
Clinical trial
A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions Among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)Status: Active (not recruiting), Estimated PCD: 2024-12-02
Clinical trial
A Multicenter, Open-Label Feasibility Study of Daratumumab With Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma With or Without HIVStatus: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
A Phase II Study of sEphB4-HSA in Kaposi SarcomaStatus: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
A Pilot Study of Nelfinavir for the Treatment of Kaposi SarcomaStatus: Completed, Estimated PCD: 2022-05-23
Clinical trial
Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion LymphomaStatus: Terminated, Estimated PCD: 2023-02-03
Clinical trial
Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of HIV-1 Associated MalignanciesStatus: Terminated, Estimated PCD: 2022-01-14
Clinical trial
A Phase I Study of Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-Selected CD34+ CellsStatus: Active (not recruiting), Estimated PCD: 2021-05-13